CARLSBAD, Calif. (AP) _ Ionis Pharmaceuticals Inc. (IONS) on Tuesday reported a loss of $4.6 million in its third quarter.
The Carlsbad, California-based company said it had a loss of 3 cents per share.
The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 13 cents per share.
The drug discovery and development company posted revenue of $145.4 million in the period, which also topped Street forecasts. Three analysts surveyed by Zacks expected $132.4 million.
Ionis Pharmaceuticals shares have risen slightly more than 2 percent since the beginning of the year. The stock has declined roughly 5 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IONS at https://www.zacks.com/ap/IONS